Rhythm Pharmaceuticals Reports the US FDA’s Approval of Imcivree (Setmelanotide) for Patients as Young as 2 Years Old
Shots: The US FDA has approved the indication expansion of Imcivree to add childre...
BMS Reports the EC’s Approval of Opdivo (Nivolumab) Plus Yervoy (Ipilimumab) as a 1L Treatment of MSI-H/dMMR Metastatic Colorectal...
Shots: The EC has approved Opdivo + Yervoy as a 1L treatment of MSI-H/dMMR unresec...
Pfizer’s Braftovi (Encorafenib) Secures the US FDA’s Accelerated Approval as a 1L Treatment of BRAF V600E-Mutant Metastatic Colore...
Shots: The US FDA has granted accelerated approval to Braftovi + cetuximab & m...
Eli Lilly Reports the US FDA’s Approval of Zepbound (Tirzepatide) to Treat Moderate-to-Severe Obstructive Sleep Apnea in Obese Adu...
Shots: The US FDA has granted approval to Zepbound for treating moderate-to-severe...
Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara)
Shots: Dong-A ST received EC approval for Imuldosa (DMB-3115), a biosimilar of Jan...
